1972
A.O. Eseola et al. / Inorganica Chimica Acta 363 (2010) 1970–1978
chromatography. The imidazole product (L2) was isolated as white
solid (1.44 g, 47.3% yield). M.p. 198–200 °C. Selected IR peaks (KBr
8.64(d, J = 4.8 Hz, 1H); 8.53(d, J = 8.0 Hz, 1H); 8.08(s, br, 1H);
7.89(dd, 7.7 Hz, 1H); 7.71(s, br, 2H); 7.64(m, 2H); 7.34(dd,
J = 4.9 Hz, 1H). 13C NMR (CDCl3, 100 MHz, TMS); 149.02, 148.57,
148.38, 137.31, 127.08, 125.61, 123.90, 121.18. Anal. Calc. for
C20H13N3.0 Á 25H2O: C, 80.11; H, 4.54; N, 14.01. Found: C, 79.60;
H, 4.63; N, 14.14%.
disc, cmÀ1):
m 3061s, 2959s, 1597s, 1572s, 1501m, 1474vs, 1454vs,
765vs, 697vs. 1H NMR (400 MHz, TMS, CDCl3); d 10.50(s, br, 1H);
8.09(d, J = 7.8 Hz, 1H); 7.67(m, 3H); 7.50(br, d, J = 5.9 Hz, 2H);
7.32(m, br, 6H); 7.09(d, J = 7.6 Hz, 1H); 2.61(s, 3H). 13C NMR
(100 MHz, TMS, CDCl3): 157.7, 147.5, 145.5, 137.4, 128.5, 127.9,
127.1, 122.8, 117.1, 24.2. Anal. Calc. for C21H17N3: C, 81.00; H,
5.50; N, 13.49 Found: C, 80.56; H, 5.59; N, 13.86%.
3.1.6. 2-(6-Methylpyridin-2-yl)-1H-phenanthro[9,10-d]imidazoles
(L6)
Obtained 0.61 g, 41.0%. M.p. 218–220 °C. Selected IR peaks (KBr
3.1.3. 2-(1-Methyl-4,5-diphenyl-1H-imidazol-2-yl)pyridine (L3)
In acetone (30 mL), 2-(4,5-diphenyl-1H-imidazol-2-yl)pyridine
(0.44 g, 1.47 mmol) and K2CO3 (0.41 g, 2.95 mmol) were refluxed
for 30 min. On cooling, iodidomethane (0.13 mL, 2.06 mmol) was
added and the reaction mixture stirred at room temperature for
24 h. Removal of solvent under vacuum followed by addition of
about 50 mL water gave white particles which were filtered,
washed with water and dried. This was purified on silica gel column
with ethyl acetate/petroleum ether (1:5) to obtain compound L3
(0.34 g, 71.4%). M.p. 121–123 °C. Selected IR peaks (KBr disc,
disc, cmÀ1):
m 3435s, 3072s, 1615m, 1595s, 1573vs, 1516m,
1461vs, 1450vs, 1427vs, 1235s, 1120m, 1038s, 796s, 752vs,
723vs. 1H NMR (CDCl3, 400 MHz, TMS): 11.45(s, br, 1H); 8.74(m,
3H); 8.34(d, J = 7.8 Hz, 1H); 8.12(d, J = 6.4 Hz, 1H); 7.76(m, 2H),
7.64(m, 3H); 7.20(d, J = 7.3 Hz, 1H); 2.66(s, 3H). 13C NMR (CDCl3,
100 MHz, TMS): 158.1, 148.5, 147.8, 137.5, 128.6, 127.1, 125.5,
123.6, 122.5, 118.2, 24.31. Anal. Calc. for C21H15N3 Á 0.9H2O: C,
76.62; H, 5.27; N, 12.77. Found: C, 76.65; H, 5.18; N, 12.79%.
3.1.7. 2-(Pyridin-2-yl)phenanthro[9,10-d]oxazole (L7)
cmÀ1):
m
3104m, 3034m, 2953w, 1606s, 1573m, 799s, 700vs. 1H
Obtained 2.50 g, 58.6%. M.p. 199–201 °C. Selected IR peaks (KBr
NMR (400 MHz, TMS, CDCl3): d 8.62(d, J = 4.8 Hz, 1H); 8.32(d,
J = 8.0 Hz, 1H); 7.81(dd, J = 7.7 Hz, 1H); 7.55(d, J = 7.2 Hz, 2H);
7.48(m, 3H); 7.41(m, 2H); 7.24(m, 1H); 7.22(dd, J = 7.2 Hz, 2H);
7.16(d, 7.2 Hz, 1H); 3.91(s, 3H). 13C NMR (100 MHz, TMS, CDCl3):
151.0, 148.3, 145.0, 137.9, 136.6, 134.7, 132.2, 131.0, 129.0, 128.7,
128.1, 126.9, 126.4, 123.7, 122.5, 34.1. Anal. Calc. for C21H17N3: C,
81.00; H, 5.50; N, 13.49. Found: C, 81.03; H, 5.52; N, 13.32%.
disc, cmÀ1):
m 3056m, 1615m, 1589vs, 1566s, 1455vs, 1425vs,
1251s, 1234s, 1082vs, 757vs, 724vs. 1H NMR (CDCl3, 400 MHz,
TMS): 8.89(d, J = 4.8 Hz, 1H); 8.73(m, 3H); 8.47(m, 2H); 7.94(dd,
J = 7.6 Hz, 1H), 7.73(m, 4H); 7.46(dd, J = 4.8 Hz, 1H). 13C NMR
(CDCl3, 100 MHz, TMS): 160.7, 150.4, 146.4, 145.7, 137.1, 135.6,
129.9, 129.2, 127.9, 127.4, 126.9, 126.4, 126.2, 125.0, 123.8,
123.5, 123.2, 123.1, 121.4, 121.1. Anal. Calc. for C20H12N2O: C,
81.07; H, 4.08; N, 9.45. Found: C, 80.84, H, 4.20, N, 9.41%.
3.1.4 2-Methyl-6-(1-methyl-4,5-diphenyl-1H-imidazol-2-yl)pyridine
(L4)
3.2. Syntheses of Ni(II) complexes C1–C9
In 30 mL solvent, the reactants 2-methyl-6-(4,5-diphenyl-1H-
imidazol-2-yl)pyridine (0.44 g, 1.40 mmol), K2CO3 (0.39 g,
2.79 mmol) and methyliodide (0.12 mL, 1.95 mmol) were subjected
to similare procedure as for compound L3 to obtain compound L4
(0.27 g, 66.1%). M.p. 120–122 °C. Selected IR peaks (KBr disc,
3.2.1. Complex C1 (L12NiCl2)
The dichloromethane (10 mL) solution of L1 (0.13 g, 0.45 mmol)
was added in drops to a stirring solution of NiCl2 Á 6H2O (54.0 mg,
0.225 mmol) in ethanol (6 mL) at room temperature. The stirring
continued for 12 h after which the resultant particles were filtered
to give C1 as light blue micro-crystals (0.13 g, 73.4%). Decomposi-
cmÀ1):
m
3100m, 3056w, 3030w, 2987w, 1604s, 1573s, 790vs. 1H
NMR (400 MHz, TMS, CDCl3): d 8.08(d, J = 7.8 Hz, 1H); 7.69(dd,
J = 7.8 Hz, 1H); 7.53(d, J = 7.3 Hz, 2H); 7.46(m, 3H); 7.40(m, 2H);
7.21(dd, J = 7.2 Hz, 2H); 7.13(dd, J = 7.6 Hz, 2H); 3.88(s, 3H);
2.60(s, 3H). 13C NMR (100 MHz, TMS, CDCl3): 157.1, 150.3, 145.2,
137.8, 137.0, 134.7, 132.0, 131.1, 131.0, 129.0, 128.6, 128.1, 127.0,
126.3, 122.0, 120.7, 34.0, 24.5. Anal. Calc. for C22H19N3: C, 81.20;
H, 5.89; N, 12.91. Found: C, 81.36; H, 5.92; N, 12.78%.
tion point (D.p.) >302 °C. Selected IR peaks (KBr, cmÀ1):
m 3285m,
3055vs, 1615vs, 1585vs, 1573s, 1535s, 1475vs, 1459vs, 774vs,
696vs. Anal. Calc. for C41H36Cl2N6NiO2: C, 63.59; H, 4.69; N,
10.85. Found: C, 63.30; H, 4.66; N, 10.58%.
3.2.2. Complex C2 (L32NiCl2)
Compounds L5–L7 were also obtained by similar procedure for
preparation of compound L1. The general procedure is as follows:
Phenanthrenequinone and the corresponding aldehyde (1 M e-
quiv.) were refluxed for 3 h in the presence of ammonium acetate
(10 M equiv.) and glacial acetic acid (0.5–1.0 mL) as catalyst. The
reaction solution was cooled and stirred with a few drops of con-
centrated aqueous ammonia at room temperature to neutralize
residual acid. The mixture was extracted 2ce with dichlorometh-
ane (60 mL and 20 mL) and the combined organic extract concen-
trated under vacuum was purified on silica gel column using
petroleum ether/dichloromethane (1:4) as eluent. The eluent por-
tions containing the respective products were collected and con-
centrated under vacuum. Addition of petroleum ether
precipitated the products which were filtered washed with petro-
leum ether and dried under vacuum at 60 °C. Reaction and analyt-
ical data for the respective ligands are as follows.
NiCl2 Á 6H2O (46.0 mg, 0.20 mmol) and L3 (0.12 g, 0.40 mmol)
were reacted in a similar manner as for C1 to obtain C2 as a blue
powder (0.15 g, 85.2%). D.p. >394 °C. Selected IR peaks (KBr,
m 3104m, 3034m, 2953w, 1606s, 1573m, 799s, 700vs. Anal.
Calc. for C42H36Cl2N6NiO: C, 65.48; H, 4.71; N, 10.91. Found: C,
cmÀ1):
65.54; H, 4.53; N, 10.87%.
3.2.3. Complex C3 (L12NiBr2)
To a THF (2 mL) solution of (DME)NiBr2 (90.0 mg, 0.29 mmol),
the THF (4 mL) solution of L1 (0.19 g, 0.64 mmol) was added in
drops and stirring continued for 12 h at room temperature. Diethyl
ether (5 mL) was added to precipitate the blue powder, which was
filtered, washed with THF/diethyl ether mixture, and dried under
vacuum to give C3 as blue powder (0.24 g, 78.8%). D.p. >312 °C. Se-
lected IR peaks (KBr, cmÀ1):
m 3433m(br), 3321m, 3106s, 3056s,
3009m, 1614s, 1584m, 1574m, 1507m, 773s, 695vs. Anal. Calc.
for C40H34Br2N6NiO2: C, 56.57; H, 4.04; N, 9.90. Found: C, 56.46;
H, 3.79; N, 9.47%.
3.1.5. 2-(Pyridin-2-yl)-1H-phenanthro[9,10-d]imidazoles (L5)
Obtained 0.48 g, 11.3%. M.p. 200–202 °C. Selected IR peaks (KBr
disc, cmÀ1):
m
3434vs, 3052s, 1614w, 1594vs, 1566s, 1455vs,
3.2.4. Complex C4 (L2NiCl2)
1445vs, 1426s, 1396m, 1234s, 1144m, 788s, 758vs, 725vs. 1H
NMR (CDCl3, 400 MHz, TMS): 11.34(s, br, 1H); 8.73(s, br, 3H);
NiCl2 Á 6H2O (0.15 g, 0.65 mmol) and L2 (0.20 g, 0.65 mmol)
were reacted in a similar manner as for C1 to obtain C4 as a yellow